Get the Stockscreener App
10.73
0.66%
0.07
After Hours:
10.73
Ekso Bionics Holdings Inc stock is traded at $10.73, with a volume of 131.78K.
It is up +0.66% in the last 24 hours and up +14.64% over the past month.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
See More
Previous Close:
$10.66
Open:
$10.53
24h Volume:
131.78K
Relative Volume:
0.07
Market Cap:
$38.24M
Revenue:
$18.28M
Net Income/Loss:
$-15.20M
P/E Ratio:
-9.7545
EPS:
-1.1
Net Cash Flow:
$-12.21M
1W Performance:
+7.09%
1M Performance:
+14.64%
6M Performance:
+165.59%
1Y Performance:
+63.32%
1-Day Range:
$10.53
$11.78
1-Week Range:
$9.865
$11.78
52-Week Range:
$2.73
$13.27
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Name
Ekso Bionics Holdings Inc
Sector
Industry
Phone
510-984-1761
Address
101 GLACIER POINT, SAN RAFAEL
Compare EKSO vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EKSO
Ekso Bionics Holdings Inc
|
10.73 | 37.99M | 18.28M | -15.20M | -12.21M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
496.70 | 177.98B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
169.94 | 48.78B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.52 | 41.08B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.32 | 37.74B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.05 | 34.80B | 28.43B | 1.16B | 1.26B | 1.4457 |
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-16 | Initiated | SunTrust | Buy |
Ekso Bionics Holdings Inc Stock (EKSO) Latest News
Global Neurorehabilitation Market Projected to Reach USD 6.96 Billion by 2035; Growing Neurological Disorder’s Prevalence to Augment Market Expansion Globally – SNS Insider - GlobeNewswire Inc.
EKSO Should I Buy - Intellectia AI
EKSO: Record Q4 revenue, improved margins, and narrowed annual net loss highlight operational progress - TradingView
EKSO BIONICS HOLDINGS, INC. SEC 10-K Report - TradingView
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Daniel Asher revises Ekso Bionics (EKSO) trust and LLC holdings - Stock Titan
Gainers Report: Whats COOTs historical returnQuarterly Trade Summary & Weekly High Momentum Picks - baoquankhu1.vn
Insider Daniel Asher adds Ekso Bionics (EKSO) shares via DBA Trading - Stock Titan
Ekso Bionics to Acquire Cloud Unit, Rebrand ChronoScale - The Globe and Mail
Armistice Capital reports 9.99% stake in Ekso Bionics (EKSO) amendment - Stock Titan
Ekso Bionics Holdings Insider Bought Shares Worth $970,069, According to a Recent SEC Filing - marketscreener.com
Ekso Bionics to Combine With Applied Digital Cloud; Issuing 138.2M Shares, Rebrands ChronoScale - TradingView
Applied Digital (NASDAQ: APLD) to control ChronoScale after Ekso stock deal - Stock Titan
Is Ekso Bionics Holdings Inc. benefiting from innovation trendsFed Meeting & Breakout Confirmation Alerts - mfd.ru
Will Ekso Bionics Holdings Inc. announce a stock splitTrade Volume Report & Daily Technical Forecast Reports - mfd.ru
Is Ekso Bionics Holdings Inc.’s growth already priced inQuarterly Portfolio Summary & Weekly High Momentum Picks - mfd.ru
Can Ekso Bionics Holdings Inc. stock deliver consistent earnings growthShare Buyback & Risk Controlled Stock Alerts - mfd.ru
EKSO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Ekso Bionics Holdings Inc. (EKSO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How The Ekso Bionics Holdings Narrative Is Shifting After Q3 And A Higher Price Target - Yahoo Finance
Support Test: Will Ekso Bionics Holdings Inc outperform the market in YEARPortfolio Performance Report & Verified Technical Signals - baoquankhu1.vn
Targets Report: What is the earnings history of ZimVie IncMarket Rally & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Setups: Is Ekso Bionics Holdings Inc being accumulated by smart moneyRecession Risk & Real-Time Volume Analysis - baoquankhu1.vn
EKSO SEC FilingsEkso Bionics 10-K, 10-Q, 8-K Forms - Stock Titan
Beat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in Focus - Yahoo Finance
Risk Report: Is Ekso Bionics Holdings Inc being accumulated by smart moneyJuly 2025 Recap & AI Powered Market Entry Strategies - baoquankhu1.vn
Is Ekso Bionics Holdings Inc. stock forming a cup and handleWeekly Profit Analysis & Technical Entry and Exit Alerts - mfd.ru
How The New Price Target Is Shaping Ekso Bionics Holdings (EKSO) Story - Yahoo Finance
Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Ekso Bionics Raises Capital via Series B Preferred - TipRanks
Ekso Bionics Signs Multiple Financing Agreements - tradingview.com
Ekso Bionics raises $5.9 million in private stock placement By Investing.com - Investing.com Nigeria
Ekso Bionics Holdings, Inc. announced that it has received $5.852 million in funding - marketscreener.com
Ekso Bionics (EKSO) Announces Private Placement and Share Warran - GuruFocus
Ekso Bionics raises $5.9 million in private stock placement - Investing.com
Ekso Bionics Prices $5.852 million Private Placement - The Manila Times
Ekso Bionics Holdings, Inc. Announces $5.9 Million Private Placement of Series B Preferred Stock and Warrants - Quiver Quantitative
Exoskeleton firm Ekso Bionics lines up $5.9M in new funding - Stock Titan
Ekso Bionics Holdings, Inc. announced that it expects to receive $5.852 million in funding - marketscreener.com
Ekso Bionics Holdings (EKSO) Price Target Increased by 22.58% to 9.69 - Nasdaq
Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
How Recent Developments Are Rewriting The Story For Ekso Bionics Holdings (EKSO) - Yahoo Finance
Is Ekso Bionics Holdings Inc. stock a safe investment in uncertain markets2025 Technical Patterns & Fast Exit and Entry Strategy Plans - ulpravda.ru
How Ekso Bionics Holdings Inc. (23E0) stock valuation compares with sectorWatch List & Low Risk Growth Stock Ideas - ulpravda.ru
How Ekso Bionics Holdings Inc. stock reacts to global recession fearsMarket Risk Summary & Reliable Entry Point Alerts - ulpravda.ru
Medical Exoskeleton Market Size, Share, Trends | Growth [2034] - Fortune Business Insights
Can Ekso Bionics Holdings Inc. stock surprise with earnings upsideWeekly Gains Report & Weekly Watchlist of Top Performers - Улправда
Can Ekso Bionics Holdings Inc. stock maintain growth trajectory2025 Bull vs Bear & Real-Time Buy Zone Alerts - Улправда
Will Ekso Bionics Holdings Inc. stock split attract more investorsRate Cut & Weekly Stock Breakout Alerts - Улправда
Why Ekso Bionics Holdings Inc. stock could benefit from AI revolutionJuly 2025 Volume & Low Drawdown Investment Strategies - Улправда
Is Ekso Bionics Holdings Inc. (23E0) stock a buy during volatile markets2025 AllTime Highs & Verified Technical Trade Signals - Улправда
Ekso Bionics Holdings Inc Stock (EKSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ekso Bionics Holdings Inc Stock (EKSO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ASHER DANIEL | 10% Owner |
Feb 19 '26 |
Buy |
9.60 |
1,200 |
11,520 |
259,992 |
| ASHER DANIEL | 10% Owner |
Feb 12 '26 |
Buy |
9.57 |
39,032 |
373,656 |
231,600 |
| ASHER DANIEL | 10% Owner |
Feb 13 '26 |
Buy |
9.04 |
27,192 |
245,687 |
258,792 |
| ASHER DANIEL | 10% Owner |
Feb 11 '26 |
Buy |
9.69 |
20,611 |
199,770 |
192,568 |
| ASHER DANIEL | 10% Owner |
Feb 10 '26 |
Buy |
9.92 |
10,200 |
101,225 |
171,957 |
| ASHER DANIEL | 10% Owner |
Feb 09 '26 |
Buy |
9.96 |
4,800 |
47,820 |
161,757 |
| ASHER DANIEL | 10% Owner |
Feb 06 '26 |
Buy |
9.86 |
194 |
1,912 |
156,957 |
| Jones Jason C | Chief Operating Officer |
Jan 06 '26 |
Sale |
9.25 |
1,320 |
12,210 |
25,621 |
| Jones Jason C | Chief Operating Officer |
Dec 09 '25 |
Sale |
4.70 |
270 |
1,269 |
26,941 |
| Wong Jerome | Chief Financial Officer |
Dec 09 '25 |
Sale |
4.70 |
1,238 |
5,819 |
24,771 |
0.54%
3.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):